Remote monitoring with tailored texts improved endocrine therapy adherence among breast cancer survivors with low symptom-management self-efficacy, with benefits becoming nonsignificant at higher self-efficacy levels.
Gregory A.Vidal, MD, PhD
Advertisement
Articles by Gregory A.Vidal, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
New York Experts Push for Coordinated Obesity Care Teams
4
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
5